brentuximab vedotin - Robuta Search

https://www.mayo.edu/research/clinical-trials/cls-20111926?&p=1 Brentuximab Vedotin In Patients With CD30-positive Nonlymphomatous Malignancies - Mayo Clinic brentuximab vedotin patients https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2025-04493&r=1 Abbreviated Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and... Abbreviated Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone for the Treatment of Stage IIB-IV Hodgkin Lymphoma brentuximab vedotin abbreviated etoposide cyclophosphamide doxorubicin https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2023-06937&r=1 Brentuximab Vedotin in Early-Stage Hodgkin Lymphoma, RADAR Trial - NCI Brentuximab Vedotin in Early-Stage Hodgkin Lymphoma, RADAR Trial brentuximab vedotin early stage hodgkin lymphoma radar trial https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/bv-avd Brentuximab vedotin with doxorubicin, vinblastine and dacarbazine (BV-AVD) | Macmillan Cancer... Brentuximab vedotin with doxorubicin, vinblastine and dacarbazine (BV-AVD) is a cancer drug treatment. It is used to treat the Hodgkin lymphoma. brentuximab vedotin doxorubicin vinblastine https://www.stjude.org/care-treatment/clinical-trials/hlhr13-hodgkin-lymphoma.html HLHR13: Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating... Learn about this clinical trial that used Adcetris, combination chemotherapy, and radiation therapy to treating patients with Hodgkin Lymphoma. brentuximab vedotin combination chemotherapy adcetris https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2023-05152&r=1 Brentuximab Vedotin in Combination with Pembrolizumab for the Treatment of Patients with CD30... Brentuximab Vedotin in Combination with Pembrolizumab for the Treatment of Patients with CD30 Positive T-cell Non-Hodgkin Lymphoma brentuximab vedotin https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2020-06645&r=1 Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular... Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma brentuximab vedotin for the https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00573&r=1 Brentuximab Vedotin and Combination Chemotherapy in Treating Patients with CD30-Positive Peripheral... Brentuximab Vedotin and Combination Chemotherapy in Treating Patients with CD30-Positive Peripheral T-cell Lymphoma brentuximab vedotin combination chemotherapy https://www.mayo.edu/research/clinical-trials/cls-20490567 A Study To Evaluate Brentuximab Vedotin Or Placebo In Combination With Lenalidomide And Rituximab... Learn more about services at Mayo Clinic. https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2020-05332&r=1 Brentuximab Vedotin and Nivolumab for the Treatment of Patients with Relapsed or Refractory... Brentuximab Vedotin and Nivolumab for the Treatment of Patients with Relapsed or Refractory Classical Hodgkin Lymphoma